AllStar Health Brands is Helping Fight the Virus: RichTV Live

AllStar Health Brands

Since the COVID-19 crisis began, healthcare stocks around the world have generally been soaring. That’s why today, Rich is interviewing the CEO of a promising healthcare stock, Allstar Health Brands Inc (OTCPK:ALST).

AllStar Health Brands is a specialty healthcare products company offering select nutritional supplements, as well as over-the-counter remedies and medicines all across North America, South America, and Europe. Headquartered in Miami, the company’s goal is to bring additional products to the market and provide new, innovative options for better health.

Rich and AllStar President and CEO Dr. Daniel Bagi discuss the company’s big news and what the future has in store for ALST.

Allstar Health Brands’ Current Initiatives

As mentioned in the company’s corporate update from January, AllStar is currently building its website to reflect its ongoing initiatives in e-commerce. Dr. Bagi and the rest of AllStar management expect to have it ready before the end of this quarter.

The company is also developing several exciting new products in the Women’s Health space. This is one of the fastest-growing market segments, and AllStar is working with specific GMP (Good Manufacturing Practices) manufacturers in the United States to bring new products to the market later this year.

Enter Your E-mail Address To Subscribe

* indicates required

On March 11, the company announced that it signed a distribution agreement with MedPharma Invest. The agreement is for the sale and marketing of a US-FDA registered, patented Over-the-Counter Medicine, Wound Cleanser. Wound Cleanser is already sold in select hospitals in the US, making it strategically poised for large-scale adoption.

Finally, AllStar Health Brands is targeting additional alliances with developers of new, yet-to-be patented products in Women’s and General Health. These alliances are slated for completion over this and next quarter.

“We have two products that we’re very close to finishing, and these will have advantages over competing products,” says Dr. Bagi.

How AllStar is Helping the Fight Against COVID-19

In its biggest and most recent news, AllStar is helping deliver rapid test kits that detect COVID-19. According to Bagi, these tests can identify signs of the virus within 10 to 15 minutes. For reference, current tests tend to take approximately 24 hours.

“Approval for these tests is expected any day now under the USFDA EUA, which is the Emergency Use Authorization,” Dr. Bagi explains.

While BioCan is the company developing the test kits, AllStar Health Brands will be responsible for delivering them.

In addition, AllStar is sourcing as much in-demand equipment as it can to meet orders from the US and South America. Specifically, it hopes to soon deliver the all-important N95 respirator to areas with a high number of coronavirus cases.

ALST is currently trading at $0.96, which represents a 4.5% decline from the start of the year. Today alone, however, the stock gained nearly 25%. No COIVD-19-related announcements have yet been released, meaning AllStar Health Brands’ stock is positioned for a potential surge.

What do you think? Does this company have what it takes to be a major supplier of healthcare products during the current pandemic? Let us know your thoughts and, as always, do your own research before investing.

For more articles like this, check out Rich’s other CEO interviews with Halo Labs (NEO: HALO) (OTCQX:AGEEF) and Defense Metals Corp (TSXV:DEFN) (OTCQB:DFMTF).

Featured image: DepositPhotos © AntonMatyukha

Please See Disclaimer

If You Liked This Article Click To Share

Risks and Disclosure:

Information provided in this correspondence is intended solely for informational purposes and is obtained from sources believed to be reliable. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained on this website is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions made or suggested and the actual results.

All statements and opinions expressed are the opinions of the author and not of or its officers. The author is wholly responsible for the validity of all statements. was not involved in any aspect of the article preparation. The author was not paid by Bitrex Inc for this article. The author did not pay to publish or syndicate this article.

This article does not constitute as investment advice. Each reader is encouraged to consult with his or her individual financial advisor; any and all actions taken by a reader as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to's terms of use and full legal disclaimer. This article is in no way a solicitation for investment. does not render general or specific investment advice. Any information on should not be considered a recommendation to buy or sell any security. does not endorse or recommend the business, products, services or securities of any company mentioned on

Futures, stocks and options trading involves substantial risk of loss and is not suitable for every investor. The valuation of futures, stocks, and options may fluctuate, and, as a result, clients may lose more than their original investment and possibly their entire investment. Any content on this website should not be relied upon as advice or construed as providing recommendations of any kind. It is your responsibility to confirm and decide which trades to make. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Please see our full disclaimer here for additional details before making any investment decisions.